|
2019 Journal Article Quinolone antibioticsPham, Thu D. M., Ziora, Zyta M. and Blaskovich, Mark A. T. (2019). Quinolone antibiotics. MedChemComm, 10 (10), 1719-1739. doi: 10.1039/c9md00120d |
|
2019 Journal Article Effects of microplate type and broth additives on microdilution MIC susceptibility assaysKavanagh, Angela, Ramu, Soumya, Gong, Yujing, Cooper, Matthew A. and Blaskovich, Mark A. T. (2019). Effects of microplate type and broth additives on microdilution MIC susceptibility assays. Antimicrobial Agents and Chemotherapy, 63 (1) e01760-18. doi: 10.1128/aac.01760-18 |
|
2018 Journal Article Design, synthesis and biological evaluation of 2-nitroimidazopyrazin-one/-es with antitubercular and antiparasitic activityJarrad, Angie M., Ang, Chee Wei, Debnath, Anjan, Hahn, Hye Jee, Woods, Kyra, Tan, Lendl, Sykes, Melissa L., Jones, Amy J., Pelingon, Ruby, Butler, Mark S., Avery, Vicky M., West, Nicholas P., Karoli, Tomislav, Blaskovich, Mark A. T. and Cooper, Matthew A. (2018). Design, synthesis and biological evaluation of 2-nitroimidazopyrazin-one/-es with antitubercular and antiparasitic activity. Journal of Medicinal Chemistry, 61 (24) acs.jmedchem.8b01578, 11349-11371. doi: 10.1021/acs.jmedchem.8b01578 |
|
2018 Journal Article Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolatePitt, Miranda E., Cao, Minh Duc, Butler, Mark S., Ramu, Soumya, Ganesamoorthy, Devika, Blaskovich, Mark A. T., Coin, Lachlan J. M. and Cooper, Matthew A. (2018). Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate. The Journal of Antimicrobial Chemotherapy, 74 (3), 582-593. doi: 10.1093/jac/dky458 |
|
2018 Journal Article Antimicrobial silver in medicinal and consumer applications: a patent review of the past decade (2007–2017)Sim, Wilson, Barnard, Ross, Blaskovich, M.A.T. and Ziora, Zyta (2018). Antimicrobial silver in medicinal and consumer applications: a patent review of the past decade (2007–2017). Antibiotics, 7 (4) 93, 93. doi: 10.3390/antibiotics7040093 |
|
2018 Journal Article Silver bullets: a new lustre on an old antimicrobial agentMöhler, Jasper S., Sim, Wilson, Blaskovich, Mark A. T., Cooper, Matthew A. and Ziora, Zyta M. (2018). Silver bullets: a new lustre on an old antimicrobial agent. Biotechnology Advances, 36 (5), 1391-1411. doi: 10.1016/j.biotechadv.2018.05.004 |
|
2018 Journal Article Detection and investigation of Eagle effect resistance to vancomycin in Clostridium difficile with an ATP-bioluminescence assayJarrad, Angie M., Blaskovich, Mark A. T., Prasetyoputri, Anggia, Karoli, Tomislav, Hansford, Karl A. and Cooper, Matthew A. (2018). Detection and investigation of Eagle effect resistance to vancomycin in Clostridium difficile with an ATP-bioluminescence assay. Frontiers in Microbiology, 9 (JUL) 1420, 1420. doi: 10.3389/fmicb.2018.01420 |
|
2018 Other Outputs Visualisation ConstructsMark Blaskovich, Matt Cooper, Mark Butler, Rhia Stone and Wanida Phetsang (2018). Visualisation Constructs. WO/2018/102890. |
|
2018 Other Outputs Glycopeptide Antibiotic ConstructsMark Blaskovich, Matt Cooper, Andrea Ranzoni, Wanida Phetsang and Marwa Hassan (2018). Glycopeptide Antibiotic Constructs. WO/2018/102889. |
|
2018 Journal Article The fight against antimicrobial resistance is confounded by a global increase in antibiotic usageBlaskovich, Mark A. T. (2018). The fight against antimicrobial resistance is confounded by a global increase in antibiotic usage. ACS Infectious Diseases, 4 (6), 868-870. doi: 10.1021/acsinfecdis.8b00109 |
|
2018 Journal Article Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniaePitt, Miranda E., Elliott, Alysha G., Cao, Minh Duc, Ganesamoorthy, Devika, Karaiskos, Ilias, Giamarellou, Helen, Abboud, Cely S., Blaskovich, Mark A. T., Cooper, Matthew A. and Coin, Lachlan J. M. (2018). Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae. Microbial Genomics, 4 (3) 000158. doi: 10.1099/mgen.0.000158 |
|
2018 Journal Article Developments in Glycopeptide AntibioticsBlaskovich, Mark A. T., Hansford, Karl A., Butler, Mark S., Jia, ZhiGuang, Mark, Alan E. and Cooper, Matthew A. (2018). Developments in Glycopeptide Antibiotics. ACS Infectious Diseases, 4 (5), 715-735. doi: 10.1021/acsinfecdis.7b00258 |
|
2017 Journal Article A template guided approach to generating cell permeable inhibitors of Staphylococcus aureus biotin protein ligasePaparella, Ashleigh S., Feng, Jiage, Blanco-Rodriguez, Beatriz, Feng, Zikai, Phetsang, Wanida, Blaskovich, Mark A. T., Cooper, Matthew A., Booker, Grant W., Polyak, Steven W. and Abell, Andrew D. (2017). A template guided approach to generating cell permeable inhibitors of Staphylococcus aureus biotin protein ligase. Tetrahedron, 74 (12), 1175-1183. doi: 10.1016/j.tet.2017.10.032 |
|
2017 Journal Article Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1Edwards, Ingrid A, Elliott, Alysha G, Kavanagh, Angela M, Blaskovich, Mark A T and Cooper, Matthew A (2017). Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1. ACS infectious diseases, 3 (12), 917-926. doi: 10.1021/acsinfecdis.7b00123 |
|
2017 Journal Article Nitroimidazoles: Molecular fireworks that combat a broad spectrum of infectious diseasesAng, Chee Wei, Jarrad, Angie M., Cooper, Matthew A. and Blaskovich, Mark A. T. (2017). Nitroimidazoles: Molecular fireworks that combat a broad spectrum of infectious diseases. Journal of Medicinal Chemistry, 60 (18), 7636-7657. doi: 10.1021/acs.jmedchem.7b00143 |
|
2017 Journal Article Investigating the interaction of octapeptin A3 with model bacterial membranesHan, Mei-Ling, Shen, Hsin-Hui, Hansford, Karl A., Schneider, Elena K., Sivanesan, Sivashangarie, Roberts, Kade D., Thompson, Philip E., Le Brun, Anton P., Zhu, Yan, Sani, Marc-Antoine, Separovic, Frances, Blaskovich, Mark A. T., Baker, Mark A., Moskowitz, Samuel M., Cooper, Matthew A., Li, Jian and Velkov, Tony (2017). Investigating the interaction of octapeptin A3 with model bacterial membranes. ACS Infectious Diseases, 3 (8), 606-619. doi: 10.1021/acsinfecdis.7b00065 |
|
2017 Journal Article From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor ModulatorsHussein, Maytham H., Schneider, Elena K., Elliott, Alysha G., Han, Meiling, Reyes-Ortega, Felisa, Morris, Faye, Blaskovich, Mark A. T., Jasim, Raad, Currie, Bart, Mayo, Mark, Baker, Mark, Cooper, Matthew A., Li, Jian and Velkov, Tony (2017). From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Microbial Drug Resistance, 23 (5), 640-650. doi: 10.1089/mdr.2016.0196 |
|
2017 Journal Article Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteriaBecker, Bernd, Butler, Mark S., Hansford, Karl A., Gallardo-Godoy, Alejandra, Elliott, Alysha G., Huang, Johnny X., Edwards, David J., Blaskovich, Mark A. T. and Cooper, Matthew A. (2017). Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria. Bioorganic and Medicinal Chemistry Letters, 27 (11), 2407-2409. doi: 10.1016/j.bmcl.2017.04.027 |
|
2017 Journal Article Institutional profile: Community for Open Antimicrobial Drug Discovery - crowdsourcing new antibiotics and antifungalsDesselle, Mathilde R., Neale, Ruth, Hansford, Karl A., Zuegg, Johannes, Elliott, Alysha G., Cooper, Matthew A. and Blaskovich, Mark A. T. (2017). Institutional profile: Community for Open Antimicrobial Drug Discovery - crowdsourcing new antibiotics and antifungals. Future Science OA, 3 (2) FSO171, FSO171. doi: 10.4155/fsoa-2016-0093 |
|
2017 Journal Article Polishing the tarnished silver bullet: the quest for new antibioticsBlaskovich, Mark A. T., Butler, Mark S. and Cooper, Matthew A. (2017). Polishing the tarnished silver bullet: the quest for new antibiotics. Antimicrobial Resistance, 61 (1), 103-114. doi: 10.1042/EBC20160077 |
